Belgium
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Belgium (BE)
2000 | 307.4 thousand |
2011 | 514.9 thousand |
2024 | 641.6 thousand |
2050 | 679.0 thousand |
Belgium is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Van der Heyden J, Institut Scientifique de Sante Publique. Enquete de sante par interview, Belgique 2008.
- Belgian Health and Examination Survey, 2018. BELHES 2018
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 307.4 | 514.9 | 641.6 | 679.0 |
Age-standardised prevalence of diabetes, % | - | 4.8 | 5.9 | 6.8 |
Proportion of people with undiagnosed diabetes, % | - | - | 37.0 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 237.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 538.1 | 556.5 |
Age-standardised prevalence of IFG, % | - | - | 5.5 | 6.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 753.0 | 438.6 | 464.3 |
Age-standardised prevalence of IGT, % | - | 7.6 | 4.2 | 4.8 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 4,331.0 | 5,377.3 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 11.6 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | 7,262.7 | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | 5.7 | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | 561.7 | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | 956.4 | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 3,649.6 | 3,471.6 |
Total diabetes-related health expenditure, ID million | - | - | 4,015.2 | 3,819.4 |
Diabetes-related health expenditure per person, USD | - | 5,862.0 | 5,688.7 | 5,112.6 |
Diabetes-related health expenditure per person, ID | - | - | 6,258.6 | 5,624.8 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 39,326.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 4,729.1 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 7,458.0 | 7,768.5 | 8,483.8 | 8,450.1 |
Population of children and adolescents (0-19 y) | - | - | 2,559,497.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 307.4 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 7,458.0 |
Population of children and adolescents (0-19 y) | - |